Hypertensive treatment in patients with metabolic syndrome
| Autor: | Arthur L.M. Swislocki, M.P. David Siegel M.D. |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Metabolic Syndrome
medicine.medical_specialty business.industry Endocrinology Diabetes and Metabolism Adrenergic beta-Antagonists Angiotensin-Converting Enzyme Inhibitors Type 2 diabetes Carbohydrate metabolism medicine.disease Calcium Channel Blockers Obesity Endocrinology Internal medicine Hypertension Internal Medicine medicine Humans In patient Metabolic syndrome business Adrenergic alpha-Antagonists Antihypertensive Agents |
| Zdroj: | Metabolic syndrome and related disorders. 8(2) |
| ISSN: | 1557-8518 |
| Popis: | The prevalence of obesity, hypertension, and type 2 diabetes mellitus—in other words, the metabolic syndrome—is increasing in the United States. In this setting, it is important to understand the effects of antihypertensives on parameters of the metabolic syndrome in addition to glucose metabolism. Here the authors review pertinent clinical studies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|